A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Administered in Multiple Oral Gel Doses to Adolescent and Adult Dental Subjects
Phase of Trial: Phase II
Latest Information Update: 24 Mar 2017
At a glance
- Drugs C 16G2 (Primary)
- Indications Dental caries
- Focus Adverse reactions
- Sponsors C3 Jian
- 22 Aug 2016 Status changed from active, no longer recruiting to completed.
- 09 Jun 2016 Planned End Date changed from 1 Apr 2016 to 1 Jun 2016.
- 17 Mar 2016 Planned End Date changed from 1 May 2016 to 1 Apr 2016, according to ClinicalTrials.gov record.